| Patent | Date |
|---|
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases
Grant 11,439,628 - Sandner , et al. September 13, 2 | 2022-09-13 |
Substituted Pyrazolo Piperidine Carboxylic Acids
App 20220274958 - VAKALOPOULOS; Alexandros ; et al. | 2022-09-01 |
Use Of Sgc Activators For The Treatment Of Ophthalmologic Diseases
App 20220241273 - SCHUBERT; William Ernst ; et al. | 2022-08-04 |
Combination Containing Sgc Activators And Mineralocorticoid Receptor Antagonists
App 20220241255 - Kolkhof; Peter ; et al. | 2022-08-04 |
Combination containing sGC activators and mineralocorticoid receptor antagonists
Grant 11,331,308 - Kolkhof , et al. May 17, 2 | 2022-05-17 |
Methods To Determine Whether A Subject Is Suitable Of Being Treated With An Agonist Of Soluble Gyanylyl Cyclase (sgc)
App 20220128561 - Hoet; Rene ; et al. | 2022-04-28 |
The Use of Non-Steroidal Mineralocorticoid Receptor Antagonists Alone or in Combination for the Treatment of Muscular or Neuromuscular Diseases
App 20210121447 - Sandner; Peter ; et al. | 2021-04-29 |
Combination Containing Sgc Stimulators And Mineralocorticoid Receptor Antagonists
App 20210121461 - Kolkhof; Peter ; et al. | 2021-04-29 |
The Use Of Sgc Activators And Sgc Stimulators For The Treatment Of Cognitive Impairment
App 20210052528 - Sandner; Peter ; et al. | 2021-02-25 |
Combination containing SGC stimulators and mineralocorticoid receptor antagonists
Grant 10,918,639 - Kolkhof , et al. February 16, 2 | 2021-02-16 |
Method of Identifying a Subgroup of Patients Suffering from DcSSc which Benefits from a Treatment with sGC Stimulators and sGC A
App 20190371469 - SANDNER; Peter ; et al. | 2019-12-05 |
Combination Containing Sgc Stimulators And Mineralocorticoid Receptor Antagonists
App 20190262340 - KOLKHOF; Peter ; et al. | 2019-08-29 |
Combination Containing Sgc Activators And Mineralocorticoid Receptor Antagonists
App 20190224176 - KOLKHOF; Peter ; et al. | 2019-07-25 |
SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis
Grant 10,265,314 - Sandner , et al. | 2019-04-23 |
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
Grant 10,189,856 - Hirth-Dietrich , et al. Ja | 2019-01-29 |
The Use Of Sgc Stimulators, Sgc Activators, Alone And Combinations With Pde5 Inhibitors For The Treatment Of Digital Ulcers (du) Concomitant To Systemic Sclerosis (ssc)
App 20180169095 - HIRTH-DIETRICH; Claudia ; et al. | 2018-06-21 |
Sgc Stimulators Or Sgc Activators And Pde5 Inhibitors In Combination With Additional Treatment For The Therapy Of Cystic Fibrosis
App 20160158233 - SANDNER; Peter ; et al. | 2016-06-09 |
Adenosine A1 Agonists For The Treatment Of Glaucoma And Ocular Hypertension
App 20150306084 - LERCHEN; Hans-Georg ; et al. | 2015-10-29 |
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
Grant 9,040,566 - Klar , et al. May 26, 2 | 2015-05-26 |
Sgc Stimulators Of Sgc Activators In Combination With Pde5 Inhbitors For The Treatment Of Erectile Dysfunction
App 20140288079 - SANDNER; Peter ; et al. | 2014-09-25 |
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
App 20140038956 - Hirth-Dietrich; Claudia ; et al. | 2014-02-06 |
Adenosine A1 Agonists For The Treatment Of Glaucoma And Ocular Hypertension
App 20130210797 - Klar; Jurgen ; et al. | 2013-08-15 |
sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS
App 20130035340 - Sandner; Peter ; et al. | 2013-02-07 |
Compounds for treating pulmonary hypertension
Grant 8,304,406 - Klein , et al. November 6, 2 | 2012-11-06 |
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
App 20120058983 - Klar; Jurgen ; et al. | 2012-03-08 |
Sgc Stimulators Or Sgc Activators In Combination With Pde5 Inhibitors For The Treatment Of Erectile Dysfunction
App 20120022028 - Sandner; Peter ; et al. | 2012-01-26 |
Sgc Stimulators, Sgc Activators And Combinations Thereof For The Treatment Of Hearing Impairment
App 20110092500 - Sandner; Peter ; et al. | 2011-04-21 |
sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
App 20100210643 - Sandner; Peter ; et al. | 2010-08-19 |
Pde Inhibitors For The Treatment Of Hearing Impairment
App 20100184769 - SANDNER; Peter | 2010-07-22 |
Compounds For Treating Pulmonary Hypertension
App 20100113452 - Klein; Martina ; et al. | 2010-05-06 |
Diaryl Urea for Treating Pulmonary Hypertension
App 20100035888 - Sandner; Peter ; et al. | 2010-02-11 |
Use Of1,4-diaryl-dihydropyrimidine-2-on Derivatives For Treating Pulmonary Arterial Hypertension
App 20100010024 - Von Nussbaum; Franz ; et al. | 2010-01-14 |
PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
App 20090186896 - Ulbrich; Ernst ; et al. | 2009-07-23 |
Diaryl Ureas for Treating Pulmonary Hypertension
App 20090176791 - Sandner; Peter ; et al. | 2009-07-09 |
Substituted Benzyloxy-Phenylmethylamide Derivatives
App 20080214654 - Lampe; Thomas ; et al. | 2008-09-04 |
Chroman derivatives
App 20050222247 - Boyer, Stephen J. ; et al. | 2005-10-06 |
| 